On February 23, 2015, Nature’s Way received a letter which constituted “a request for documents and information relating to an ongoing investigation by the New York State Office of the Attorney General (“NYAG”) concerning the authenticity and purity of herbal dietary supplements and associated marketing.” The letter from the NYAG makes no allegations against Nature’s Way and provides no indications of any quality or compliance problem with any Nature’s Way product. The letter is simply a “request” for documents and information.
Nature’s Way products are produced in accordance with the federal Food and Drug Administration’s (FDA’s) Dietary Supplement Good Manufacturing Practices (GMPs), 21 CFR 111. Nature’s Way is audited by FDA to confirm compliance and continues to hold Dietary Supplement GMP Certification through NSF International, a GMP Certificate from the Australian Department of Health’s Therapeutic Goods Association (TGA) and is a licensed site for the production of Natural Health Products (NHPs) marketed in Canada. Nature’s Way intends to cooperate with the NYAG request for documents and information, as we are proud of our Quality Assurance processes and the steps that we take to both comply with the law and produce products of the highest quality.
For Immediate Release:
Schwabe North America Announces $10M+ Expansion for Enzymatic Therapy, Nature’s Way and Integrative Therapeutics Brands - Creating Over 100 New Jobs
State of Wisconsin incentive package supports expansion and consolidation
Green Bay, WI—October 22, 2009 — At a press conference with Wisconsin Governor Jim Doyle, Schwabe North America, Inc. announced an over $10 million dollar expansion and consolidation of several of its operations into its Green Bay facility. In addition to extensively remodeling and upgrading the existing Labs, Product Development, Quality Control and Manufacturing divisions, a new 100,000 square foot distribution center is being completed. Scheduled to commence operations on December 1, 2009, it will distribute all the company’s brands including Nature’s Way®, Boericke & Tafel, Enzymatic Therapy, Integrative Therapeutics™ and PhytoPharmica®.
The state of Wisconsin has provided an incentive package that includes a $500,000 forgivable loan and $400,000 in tax credits to support the expansion and creation of new jobs. The Schwabe North America project will retain the company’s 280+ Wisconsin jobs and result in the creation of over 100 new operational, professional and administrative jobs.
“I have worked hard as Governor to make Wisconsin a friendly place to do business, and am thrilled that Enzymatic Therapy has decided to consolidate its operations here in Wisconsin,” Governor Doyle said. “Today’s announcement shows that when we support good, Wisconsin businesses and their workers, we can keep our state home to some of the greatest and most promising businesses in the world.”
“Our significant investment in the future of our North American operations underscores our commitment to improve health throughout the world through the highest standard of clinically proven phyto-medicines”, said Dr. Dirk Reischig, Chairman, Dr. Willmar Schwabe GmbH & Co. KG
"I am exceptionally proud of all our Associates and their great efforts over the years, which served to create a significant growth platform for our current and many future employees. Our business is focused on improving lives, and with the assistance of the State of Wisconsin, and the City of Green Bay, we will expand our operations to better serve consumers and patients throughout North America,” said Randy J. Rose, Schwabe North America President and CEO.